TScan Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LYNX1 CAPITAL MANAGEMENT LP | 05/15/2025 | 5.36 M | $7.39 M | 0.00% | 4.13% |
BVF INC/IL | 05/15/2025 | 4.89 M | $6.75 M | 63.56% | 3.77% |
BLACKROCK, INC. | 05/02/2025 | 4.88 M | $6.73 M | -1.67% | 3.76% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 3.50 M | $4.83 M | 0.00% | 2.70% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 2.78 M | $3.84 M | 0.00% | 2.15% |
VANGUARD GROUP INC | 05/09/2025 | 2.36 M | $3.25 M | -1.08% | 1.82% |
PROPEL BIO MANAGEMENT, LLC | 05/15/2025 | 2.09 M | $2.88 M | 0.00% | 1.61% |
CHECKPOINT CAPITAL L.P. | 05/15/2025 | 2.02 M | $2.78 M | 14.90% | 1.56% |
DEER MANAGEMENT CO. LLC | 05/15/2025 | 1.25 M | $1.72 M | 0.00% | 0.96% |
ALPHABET INC. | 05/02/2025 | 1.08 M | $1.49 M | 0.00% | 0.83% |
SIMPLIFY ASSET MANAGEMENT INC. | 05/13/2025 | 1.05 M | $1.44 M | 0.00% | 0.81% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.02 M | $1.40 M | 5.38% | 0.78% |
ABRDN PLC | 05/13/2025 | 891.45 K | $1.23 M | 0.88% | 0.69% |
STATE STREET CORP | 05/15/2025 | 817.25 K | $1.13 M | 2.04% | 0.63% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 600.00 K | $828.00 K | 409.13% | 0.46% |
MORGAN STANLEY | 05/15/2025 | 592.97 K | $818.30 K | 43.63% | 0.46% |
NORTHERN TRUST CORP | 05/13/2025 | 330.02 K | $455.43 K | 2.46% | 0.25% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 270.10 K | $372.66 K | -3.55% | 0.21% |
JPMORGAN CHASE & CO | 05/12/2025 | 265.10 K | $365.84 K | 297.12% | 0.20% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 231.18 K | $319.02 K | 100.00% | 0.18% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 170.35 K | $235.08 K | 13.48% | 0.13% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 170.35 K | $235.08 K | 6.02% | 0.13% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 169.71 K | $234.19 K | 1,501.00% | 0.13% |
BROWN BROTHERS HARRIMAN & CO | 05/14/2025 | 143.05 K | $197.41 K | 0.00% | 0.11% |
UBS GROUP AG | 05/13/2025 | 123.44 K | $170.35 K | 34.38% | 0.10% |
STIFEL FINANCIAL CORP | 05/14/2025 | 116.45 K | $160.70 K | 6.16% | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 113.30 K | $156.35 K | 6.99% | 0.09% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 112.94 K | $155.86 K | 0.00% | 0.09% |
NEWEDGE WEALTH, LLC | 05/09/2025 | 91.46 K | $126.22 K | 0.00% | 0.07% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 90.20 K | $124.48 K | 100.00% | 0.07% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 88.14 K | $121.64 K | -0.19% | 0.07% |
LETKO, BROSSEAU & ASSOCIATES INC | 05/08/2025 | 77.10 K | $106.40 K | 112.98% | 0.06% |
05/12/2025 | 69.96 K | $96.55 K | 100.00% | 0.05% | |
BARCLAYS PLC | 05/15/2025 | 61.85 K | $86.00 K | -8.38% | 0.05% |
CITADEL ADVISORS LLC | 05/15/2025 | 54.39 K | $75.06 K | -61.86% | 0.04% |
DEUTSCHE BANK AG\ | 05/09/2025 | 52.56 K | $72.53 K | 149.35% | 0.04% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 51.84 K | $71.54 K | -20.41% | 0.04% |
RHUMBLINE ADVISERS | 05/29/2025 | 50.02 K | $69.02 K | 6.86% | 0.04% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 49.00 K | $67.62 K | 100.00% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 48.60 K | $67.07 K | 88.13% | 0.04% |
PALE FIRE CAPITAL SE | 05/14/2025 | 47.73 K | $65.87 K | 9.17% | 0.04% |
GSA CAPITAL PARTNERS LLP | 05/08/2025 | 41.82 K | $58.00 K | 100.00% | 0.03% |
DC INVESTMENTS MANAGEMENT, LLC | 05/14/2025 | 35.56 K | $49.08 K | 0.00% | 0.03% |
HSBC HOLDINGS PLC | 05/14/2025 | 35.04 K | $49.41 K | 100.00% | 0.03% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 33.68 K | $46.48 K | 75.29% | 0.03% |
CITIGROUP INC | 05/12/2025 | 28.15 K | $38.84 K | -30.06% | 0.02% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 05/13/2025 | 27.00 K | $37.26 K | -89.65% | 0.02% |
BANK OF MONTREAL /CAN/ | 05/13/2025 | 24.99 K | $34.49 K | 100.00% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 23.24 K | $32.07 K | 4.61% | 0.02% |
FMR LLC | 05/12/2025 | 21.88 K | $30.19 K | 1,408.83% | 0.02% |
TScan Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of TScan Therapeutics, Inc.. The most heavily invested institutionals were:
IFP Advisors, Inc: 0
ROTHSCHILD INVESTMENT LLC: 0
RHUMBLINE ADVISERS: 0
PRUDENTIAL FINANCIAL INC: 0
DEUTSCHE BANK AG\: 0
ProShare Advisors LLC: 0
29.89% of TScan Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 28.40 M shares in the last 24 months. This purchase volume represents approximately $51.40 M in transactions.